strategies for treatment-resistant depression

New evidence will improve strategies for treatment-resistant depression. More than HALF of patients continue to have symptoms after initial treatment for depression.

Switching to a different antidepressant is helpful in about 25% of patients who don't respond to an SSRI.

A patient may not even need to switch to a different class. For example, patients who don't respond to citalopram are as likely to respond to sertraline as they are to venlafaxine or bupropion.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote